View Financial HealthPsyched Wellness 배당 및 자사주 매입배당 기준 점검 0/6Psyched Wellness 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률0%자사주 매입 수익률총 주주 수익률0%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Mar 12Psyched Wellness Ltd. announced that it expects to receive CAD 1.719307 million in funding from Gotham Green Partners, LLC and affiliates and or co-investors of Gotham GreenPsyched Wellness Ltd. announced that it has entered into a non-binding term sheet with returning investors Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. pursuant to which the Company shall complete a non-brokered private placement and will issue 170,228,410 common shares and common share purchase warrants for aggregate gross proceeds of up to CAD 1,719,306.941 on March 11, 2026. The Offering will be led by Gotham Green, and it may include affiliates and/or co-investors of Gotham Green. The company will raise proceeds in two tranches of up to CAD 859,653.47 each, subject to closing conditions. The Offering will consist of issuances of Common Shares at a price of CAD 0.0101 per Common Share and Warrants at a price of CAD 0.005 per Warrant. Each Warrant will entitle the holder thereof to acquire one additional Common Share at a price of CAD 0.0051 per Additional Share at any time on or before the Warrant expiry date, set sixty (60) months following the applicable closing date. The Company has obtained approval from the Canadian Securities Exchange (the "CSE") to issue the Common Shares and Warrants at a price lower than CAD 0.05 as the Offering Price is above the volume weighted average trading price of the Common Shares on the CSE for the 20 trading day period ending March 10, 2026. The Offering will be offered for purchase and sale to investors in the United States on a private placement basis. The initial tranche is scheduled to close on or about March 18, 2026 (the "Tranche 1 Closing Date") for aggregate gross proceeds of CAD 859,653.47 (the "Initial Tranche"). Subject to the policies of the CSE, closing of the second and final tranche could be for up to CAD 859,653.47 ("Tranche 2"). The Investor Group has no obligation to fund Tranche 2, and may elect to complete Tranche 2 in whole or in part or not at all in the Investor Group's sole discretion. Additionally, the closing of Tranche 2 shall be subject to satisfactory completion of due diligence in the Investor Group's sole discretion. All securities issued under the Offering will be subject to a four month and one day hold period from the applicable closing date and applicable legends as required pursuant to the U.S. Securities Act. Closing of the Offering is subject to customary closing conditions, including the approval of the CSE.공시 • Nov 27Psyched Wellness Ltd. Launches CalmerPsyched Wellness Ltd. announced the launch of Calmer, a new product offering that delivers twice the potency of its product, Calm. The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60 ml formats, reducing the mushroom taste while maintaining potency and consumer experience. The launch coincides with Psyched's Black Friday promotion, offering customers a 40% discount site-wide (excluding merch) through December 1, 2025.공시 • Apr 10AME Wellness Inc. Working with its Advisors, Zerkalo LLC Completes an Initial Pilot Run of New Dietary Supplement in Form of 4 oz ShotPsyched Wellness Ltd. announced that its US subsidiary, AME Wellness Inc., working with its advisors, Zerkalo LLC, have completed an initial pilot run of new dietary supplement in form of a 4 oz shot. The purpose of this pilot run is to beta test the shot with a select target group of consumers and gather feedback on the taste, the effect, and marketing data relating to the product. As part of this process, the Company will stress test its website, 3pl and shipping process to ensure that its fulfilment capabilities are in place in advance of the product launch.공시 • Mar 04Psyched Wellness Ltd., Annual General Meeting, May 15, 2025Psyched Wellness Ltd., Annual General Meeting, May 15, 2025.공시 • Nov 27Psyched Wellness Ltd. Announces Resignation of Harrison Aaron as DirectorPsyched Wellness Ltd. announced that Harrison Aaron, a nominee of Gotham Green Partners, LLC ("Gotham Green"), has resigned as a director of the Company effective November 22, 2024.공시 • Jun 22Psyched Wellness Ltd. Announces Board ChangesPsyched Wellness Ltd. announced that Amanda Galbraith has resigned as a director of the Company effective June 19, 2023. The Company also announced that Harrison Aaron has been appointed as director effective June 19, 2023. Harrison Aaron: Mr. Aaron is a Principal at Santa Monica based investment firm Gotham Green Partners, LLC ("Gotham Green") having joined the firm in early 2019. During his time at Gotham Green, in addition to helping lead the firm's broader investment efforts, he co-founded cannabis e-commerce retail and delivery business Amuse.com (currently serving Los Angeles, the Bay Area, and Sacramento), as well as co-founding Sandland Sleep (SandlandSleep.com), nationwide seller of highly-effective natural sleep aids, and is currently serving on the boards of both companies, as well as serving on the boards of VIOLA Brands and Engin Sciences. Prior to his time at Gotham Green, from 2013 to 2019, he covered the consumer sector as a senior analyst on the investment team at NYC-based JANA Partners, a multi-billion-dollar hedge fund investing in companies undergoing, or with the potential to undergo, value-unlocking changes. Mr. Aaron began his career on Goldman Sachs' Hedge Fund Strategies and Cross Asset Sales teams from 2009-2013, after graduating magna cum laude and Phi Beta Kappa from Colgate University, with high honors in Mathematical Economics.New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$8.63m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (CA$72k revenue, or US$54k). Market cap is less than US$10m (US$8.63m market cap).공시 • May 20Psyched Wellness Ltd., Annual General Meeting, Jul 11, 2023Psyched Wellness Ltd., Annual General Meeting, Jul 11, 2023.공시 • Feb 03Psyched Wellness Ltd. Adds New Bottle Size for Their Amanita Muscaria Extract CalmPsyched Wellness Ltd. announced that they will be launching a new larger bottle size for their proprietary Amanita Muscaria Extract (AME-1) product Calm, on February 28th 2023. The new size will provide customers with double the servings per bottle, in a 60ml package. Calm is the first legal Amanita Muscaria extract available for sale in the USA.공시 • Aug 01Psyched Wellness Ltd. announced that it has received CAD 4.05606 million in fundingOn July 31, 2020, Psyched Wellness Ltd. (OTCPK:DCNP.F) closed the transaction. The company issued 1,875,595 common shares for gross proceeds of CAD $187,559.5 in its final tranche.공시 • Jul 30Psyched Wellness Corp. acquired Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction.Psyched Wellness Corp. acquired Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction on May 5, 2020. Pursuant to the acquisition Duncan Park Holdings Corporation acquired all of the outstanding common shares of Psyched Wellness in exchange for common shares of the Duncan Park Holdings Corporation on a one for one basis. The shareholders of Psyched Wellness were issued an aggregate of 18 million common shares. Duncan Park Holdings Corporation became the sole shareholder of all of the outstanding securities of Psyched Wellness and will carry on Psyched's business. As part of the transaction, Duncan Park Holdings Corporation will seek shareholder approval at its next meeting of shareholders to approve a change to the Duncan Park Holdings Corporation name to Psyched Wellness Ltd. or such other name. As a result of the transaction, Jeffrey Stevens, will be the Director and Chief Executive Officer, Keith Li, will be the Chief Financial Officer and Corporate Secretary, David Shisel, will be the Chief Operating Officer, Michael Nederhoff, will be the Director (Chairman), Terry Booth, Nicholas Kadysh, and Chris Hazelton, will act as the Directors of the combined company. Psyched Wellness Corp. completed the acquisition of Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction on May 5, 2020.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 PSYC.F 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: PSYC.F 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Psyched Wellness 배당 수익률 vs 시장PSYC.F의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (PSYC.F)n/a시장 하위 25% (US)1.4%시장 상위 25% (US)4.2%업계 평균 (Personal Products)3.3%분석가 예측 (PSYC.F) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 PSYC.F 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 PSYC.F 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 PSYC.F 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: PSYC.F 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YUS 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/23 19:22종가2026/05/21 00:00수익2026/02/28연간 수익2025/11/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Psyched Wellness Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Mar 12Psyched Wellness Ltd. announced that it expects to receive CAD 1.719307 million in funding from Gotham Green Partners, LLC and affiliates and or co-investors of Gotham GreenPsyched Wellness Ltd. announced that it has entered into a non-binding term sheet with returning investors Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. pursuant to which the Company shall complete a non-brokered private placement and will issue 170,228,410 common shares and common share purchase warrants for aggregate gross proceeds of up to CAD 1,719,306.941 on March 11, 2026. The Offering will be led by Gotham Green, and it may include affiliates and/or co-investors of Gotham Green. The company will raise proceeds in two tranches of up to CAD 859,653.47 each, subject to closing conditions. The Offering will consist of issuances of Common Shares at a price of CAD 0.0101 per Common Share and Warrants at a price of CAD 0.005 per Warrant. Each Warrant will entitle the holder thereof to acquire one additional Common Share at a price of CAD 0.0051 per Additional Share at any time on or before the Warrant expiry date, set sixty (60) months following the applicable closing date. The Company has obtained approval from the Canadian Securities Exchange (the "CSE") to issue the Common Shares and Warrants at a price lower than CAD 0.05 as the Offering Price is above the volume weighted average trading price of the Common Shares on the CSE for the 20 trading day period ending March 10, 2026. The Offering will be offered for purchase and sale to investors in the United States on a private placement basis. The initial tranche is scheduled to close on or about March 18, 2026 (the "Tranche 1 Closing Date") for aggregate gross proceeds of CAD 859,653.47 (the "Initial Tranche"). Subject to the policies of the CSE, closing of the second and final tranche could be for up to CAD 859,653.47 ("Tranche 2"). The Investor Group has no obligation to fund Tranche 2, and may elect to complete Tranche 2 in whole or in part or not at all in the Investor Group's sole discretion. Additionally, the closing of Tranche 2 shall be subject to satisfactory completion of due diligence in the Investor Group's sole discretion. All securities issued under the Offering will be subject to a four month and one day hold period from the applicable closing date and applicable legends as required pursuant to the U.S. Securities Act. Closing of the Offering is subject to customary closing conditions, including the approval of the CSE.
공시 • Nov 27Psyched Wellness Ltd. Launches CalmerPsyched Wellness Ltd. announced the launch of Calmer, a new product offering that delivers twice the potency of its product, Calm. The Company has also enhanced the flavour profile of Calm in both the 30 ml and 60 ml formats, reducing the mushroom taste while maintaining potency and consumer experience. The launch coincides with Psyched's Black Friday promotion, offering customers a 40% discount site-wide (excluding merch) through December 1, 2025.
공시 • Apr 10AME Wellness Inc. Working with its Advisors, Zerkalo LLC Completes an Initial Pilot Run of New Dietary Supplement in Form of 4 oz ShotPsyched Wellness Ltd. announced that its US subsidiary, AME Wellness Inc., working with its advisors, Zerkalo LLC, have completed an initial pilot run of new dietary supplement in form of a 4 oz shot. The purpose of this pilot run is to beta test the shot with a select target group of consumers and gather feedback on the taste, the effect, and marketing data relating to the product. As part of this process, the Company will stress test its website, 3pl and shipping process to ensure that its fulfilment capabilities are in place in advance of the product launch.
공시 • Mar 04Psyched Wellness Ltd., Annual General Meeting, May 15, 2025Psyched Wellness Ltd., Annual General Meeting, May 15, 2025.
공시 • Nov 27Psyched Wellness Ltd. Announces Resignation of Harrison Aaron as DirectorPsyched Wellness Ltd. announced that Harrison Aaron, a nominee of Gotham Green Partners, LLC ("Gotham Green"), has resigned as a director of the Company effective November 22, 2024.
공시 • Jun 22Psyched Wellness Ltd. Announces Board ChangesPsyched Wellness Ltd. announced that Amanda Galbraith has resigned as a director of the Company effective June 19, 2023. The Company also announced that Harrison Aaron has been appointed as director effective June 19, 2023. Harrison Aaron: Mr. Aaron is a Principal at Santa Monica based investment firm Gotham Green Partners, LLC ("Gotham Green") having joined the firm in early 2019. During his time at Gotham Green, in addition to helping lead the firm's broader investment efforts, he co-founded cannabis e-commerce retail and delivery business Amuse.com (currently serving Los Angeles, the Bay Area, and Sacramento), as well as co-founding Sandland Sleep (SandlandSleep.com), nationwide seller of highly-effective natural sleep aids, and is currently serving on the boards of both companies, as well as serving on the boards of VIOLA Brands and Engin Sciences. Prior to his time at Gotham Green, from 2013 to 2019, he covered the consumer sector as a senior analyst on the investment team at NYC-based JANA Partners, a multi-billion-dollar hedge fund investing in companies undergoing, or with the potential to undergo, value-unlocking changes. Mr. Aaron began his career on Goldman Sachs' Hedge Fund Strategies and Cross Asset Sales teams from 2009-2013, after graduating magna cum laude and Phi Beta Kappa from Colgate University, with high honors in Mathematical Economics.
New Risk • Jun 08New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: US$8.63m This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Earnings have declined by 47% per year over the past 5 years. Revenue is less than US$1m (CA$72k revenue, or US$54k). Market cap is less than US$10m (US$8.63m market cap).
공시 • May 20Psyched Wellness Ltd., Annual General Meeting, Jul 11, 2023Psyched Wellness Ltd., Annual General Meeting, Jul 11, 2023.
공시 • Feb 03Psyched Wellness Ltd. Adds New Bottle Size for Their Amanita Muscaria Extract CalmPsyched Wellness Ltd. announced that they will be launching a new larger bottle size for their proprietary Amanita Muscaria Extract (AME-1) product Calm, on February 28th 2023. The new size will provide customers with double the servings per bottle, in a 60ml package. Calm is the first legal Amanita Muscaria extract available for sale in the USA.
공시 • Aug 01Psyched Wellness Ltd. announced that it has received CAD 4.05606 million in fundingOn July 31, 2020, Psyched Wellness Ltd. (OTCPK:DCNP.F) closed the transaction. The company issued 1,875,595 common shares for gross proceeds of CAD $187,559.5 in its final tranche.
공시 • Jul 30Psyched Wellness Corp. acquired Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction.Psyched Wellness Corp. acquired Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction on May 5, 2020. Pursuant to the acquisition Duncan Park Holdings Corporation acquired all of the outstanding common shares of Psyched Wellness in exchange for common shares of the Duncan Park Holdings Corporation on a one for one basis. The shareholders of Psyched Wellness were issued an aggregate of 18 million common shares. Duncan Park Holdings Corporation became the sole shareholder of all of the outstanding securities of Psyched Wellness and will carry on Psyched's business. As part of the transaction, Duncan Park Holdings Corporation will seek shareholder approval at its next meeting of shareholders to approve a change to the Duncan Park Holdings Corporation name to Psyched Wellness Ltd. or such other name. As a result of the transaction, Jeffrey Stevens, will be the Director and Chief Executive Officer, Keith Li, will be the Chief Financial Officer and Corporate Secretary, David Shisel, will be the Chief Operating Officer, Michael Nederhoff, will be the Director (Chairman), Terry Booth, Nicholas Kadysh, and Chris Hazelton, will act as the Directors of the combined company. Psyched Wellness Corp. completed the acquisition of Duncan Park Holdings Corporation (OTCPK:DCNP.F) in a reverse merger transaction on May 5, 2020.